Hetero Labs Limited Unit V FDA Record
- Latest inspection VAI · Aug 12, 2022
- 1 Class I recall
- Last warning letter 2017
Hetero Labs Limited Unit V has 11 FDA recalls (1 Class I), 5 inspections, 0 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to Hetero Labs Limited Unit V, the most recent on Aug 15, 2017.
- Latest recall
- D-0484-2026 · Class II · Mar 26, 2026
- Latest inspection
- Aug 12, 2022 · VAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 11 (1 Class I) | Nov 15, 2026 | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 5 | Nov 17, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 1 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
Hetero Labs Limited Unit V: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 1 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 1 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 1 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 8 | 1 |
| 2017 | 0 | 0 | 1 | 1 | 0 |
Reviewing Hetero Labs Limited Unit V as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Hetero Labs Limited Unit V yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Hetero Labs Limited Unit V FDA Warning Letters
| Issued | Subject | Issuing office | Close-out letter |
|---|---|---|---|
| Aug 15, 2017 · Record page |
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0484-2026 | Class II | Pantoprazole Sodium, Delayed-Release Tablets, USP, 40 mg, 1000-count bottle, Rx only, Manufactured… | Mar 26, 2026 |
| D-1545-2020 | Class II | Losartan Potassium Tablets USP, 50 mg, 90 count bottles, Rx only, Manufactured for: Camber… | Aug 6, 2020 |
| D-1213-2018 | Class II | Montelukast Sodium Tablets, 10 mg*, 30-count bottles, Rx Only, By: Hetero, Hetero Labs Limited… | Aug 20, 2018 |
| D-0081-2019 | Class I | Montelukast Sodium Tablets 10 mg, 30-count bottle, Rx Only, By: Hetero Hetero Labs Limited, Unit V… | Aug 15, 2018 |
| D-1114-2018 | Class II | Camber Pharmaceuticals, Inc. Valsartan Tablets, USP, 80 mg, 90 count bottles, Rx Only Manufactured… | Aug 8, 2018 |
| D-1113-2018 | Class II | Camber Pharmaceuticals, Inc. Valsartan Tablets, USP, 40 mg, 30 Tablets Rx Only Manufactured for… | Aug 8, 2018 |
| D-1116-2018 | Class II | Camber Pharmaceuticals, Inc. Valsartan Tablets, USP, 320 mg, 90 tablets, Rx Only Manufactured for… | Aug 8, 2018 |
| D-1115-2018 | Class II | Camber Pharmaceuticals, Inc. Valsartan Tablets, USP, 160 mg, 90 tablets Rx Only Manufactured for… | Aug 8, 2018 |
| D-0602-2018 | Class II | Valacyclovir Tablets USP 1 gram, 30-count bottle, Rx Only, Manufactured for Camber Pharmaceuticals… | Feb 13, 2018 |
| D-0601-2018 | Class II | Valganciclovir Tablets, USP, 450 mg, 60-count bottle, Rx Only, Manufactured for Camber… | Feb 13, 2018 |
| D-0415-2018 | Class II | Famciclovir Tablets, 500 mg, 30-count bottles, Rx Only, Manufactured For: Camber Pharmaceuticals… | Dec 22, 2017 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Aug 12, 2022 | Mahabubnagar, India | Drugs | Voluntary Action Indicated (VAI) | 3008307735 |
| Dec 16, 2016 | Mahabubnagar, India | Drugs | Official Action Indicated (OAI) | 3008307735 |
| May 1, 2015 | Mahabubnagar, India | Drugs | No Action Indicated (NAI) | 3008307735 |
| May 24, 2013 | Mahabubnagar, India | Drugs | Voluntary Action Indicated (VAI) | 3008307735 |
| Nov 19, 2010 | Mahabubnagar, India | Drugs | No Action Indicated (NAI) | 3008307735 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
Compliance Actions
FDA's compliance actions data lists 1 compliance action under Hetero Labs Limited Unit V: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3008307735 | Mahabubnagar, India | 5 | Aug 12, 2022 |
Hetero Labs Limited Unit V and the FDA: common questions
Has Hetero Labs Limited Unit V received an FDA warning letter?
Yes. FDA has issued 1 warning letter to Hetero Labs Limited Unit V. The most recent is dated Aug 15, 2017.
Has Hetero Labs Limited Unit V received an FDA Form 483?
FDA has not published a Form 483 for "Hetero Labs Limited Unit V" in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Hetero Labs Limited Unit V?
The most recent FDA inspection on file ended Aug 12, 2022 at Mahabubnagar, India and was classified VAI. FDA has 5 inspections of Hetero Labs Limited Unit V on file, 1 of them classified OAI (official action indicated).
Has Hetero Labs Limited Unit V had an FDA recall?
Yes. Hetero Labs Limited Unit V has 11 FDA recalls on record, 1 of them Class I, the most serious class. The most recent started Mar 26, 2026.
Need more than this page shows? Ask about Hetero Labs Limited Unit V in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.